NIMSBinars Hugo M Santos JPEG

October 29 

We had an honor to host

Dr. Hugo M. Santos, from NOVA FCT, who was talking about

‘Harnessing Proteomics for Predictive Therapeutic Combinations’.

Short Bio

Dr. Hugo Santos is an alumnus of NOVA University Lisbon, where he earned a degree in Applied Chemistry, specializing in Bioorganic Chemistry. Building on his expertise in Bioorganic Chemistry and Molecular Biology, he pursued a PhD in Biochemistry in collaboration with NOVA and the Turku Centre for Biotechnology (Finland), focusing on MALDI-TOF-MS for protein analysis. After his PhD, Dr. Santos advanced mass spectrometry techniques at the University of Vigo, Spain, before transitioning to biomedical applications at the Institute of Biotechnology and Biomedicine in Barcelona. Upon returning to NOVA in 2013, Dr. Santos pioneered nano-proteomics methods and established the Laboratory for Biological Mass Spectrometry – Isabel Moura. In 2016, he was awarded the prestigious FCT Investigator Starting Grant, allowing him to develop MS-based proteomics techniques for studying renal cell carcinoma and bladder cancer. His research led to the creation of the Differential Personal Pathway Index for predicting bladder cancer recurrence, now being expanded to breast cancer in collaboration with Harvard Medical School. Currently a tenure-track Assistant Researcher at LAQV, NOVA University Lisbon, Dr. Santos’ research integrates biochemistry, OMICS, sustainability, bioinformatics, and thermodynamic-based methods for early pathology detection and the development of reliable screening protocols. His international recognition is reflected in numerous collaborations, keynote lectures, and over 100 peer-reviewed publications.